Rapport Therapeutics Inc

RAPP NASDAQ Santé & Biotech États-Unis
34.99 $
5.71 %

Rapport Therapeutics Inc est engagée dans le développement de traitements innovants en oncologie.

Performance & Momentum

6 Months 29.02 %
1 Year 272.23 %
3 Years 68.22 %
5 Years 68.22 %

Similar stocks to Rapport Therapeutics Inc

Anantys Community

Be the first to share your analysis on Rapport Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases